Discovery Laboratories Inc (DSCO)

1.77
0.03 1.61
NASDAQ : Health Care
Prev Close 1.80
Open 1.82
Day Low/High 1.70 / 1.82
52 Wk Low/High 1.42 / 8.12
Volume 12.44K
Avg Volume 94.60K
Exchange NASDAQ
Shares Outstanding 8.19M
Market Cap 31.62M
EPS -7.25
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Your September Biotech Back-to-School Calendar

Your September Biotech Back-to-School Calendar

The biotech sector hews close to an academic calendar and September marks the start of the busy, event-filled push into the end of the year.

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Discovery Laboratories Inc Stock Downgraded (DSCO)

Discovery Laboratories Inc Stock Downgraded (DSCO)

Discovery Laboratories (Nasdaq:DSCO) has been downgraded by TheStreet Ratings from from a hold to sell.

Ratings Changes Today

Upgrades: APA, DIOD, HALL, HCN, HGT, HMPR, LABC, POZN, VLCCF, WGL Downgrades: BBOX, CIB, DNKN, DSCO, EBS, ECPG, ERII, EVC, FLY, HILL, JAZZ, LBTYA, LBTYB, NSEC, PCO, PHG, PHMD, PRO, ROIA, ROIAK, SINA, SP, SUNE, VIV Initiations: AFH, APAM, LMCA, LMCB Read on to get TheStreet Quant Ratings' detailed report:

First Week of June 21st Options Trading For Discovery Laboratories (DSCO)

First Week of June 21st Options Trading For Discovery Laboratories (DSCO)

Investors in Discovery Laboratories, Inc. saw new options become available this week, for the June 21st expiration.

The Recent Performance of 'Baker Brother Biotech Stocks' is Awful

The Recent Performance of 'Baker Brother Biotech Stocks' is Awful

Healthcare's most closely followed hedge fund is losing money during the biotech bubble burst.

Interesting DSCO Put And Call Options For May 17th

Interesting DSCO Put And Call Options For May 17th

Investors in Discovery Laboratories, Inc. saw new options become available this week, for the May 17th expiration.

Discovery Laboratories Inc. Stock Upgraded (DSCO)

Discovery Laboratories Inc. Stock Upgraded (DSCO)

Discovery Laboratories (Nasdaq:DSCO) has been upgraded by TheStreet Ratings from a sell to hold.

Ratings Changes Today

Upgrades: ANAC, AUDC, AVHI, CATO, CUNB, DEG, DSCO, EVK, ORBC, OSUR, PHMD, QADA, QADB Downgrades: BXE, INTL Initiations: BFAM Read on to get TheStreet Quant Ratings' detailed report:

First Week of DSCO October 18th Options Trading

First Week of DSCO October 18th Options Trading

Investors in Discovery Laboratories, Inc. saw new options become available this week, for the October 18th expiration.

4 Biotech Stocks Under $10 to Watch

4 Biotech Stocks Under $10 to Watch

Keep these under-$10 biotech stocks trading on unusual volume on your radar.

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Interesting DSCO Put Options For February 22nd

Interesting DSCO Put Options For February 22nd

Investors in Discovery Laboratories, Inc. saw new options begin trading this week, for the February 22nd expiration.

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

First Week Of DSCO December 21st Options Trading

First Week Of DSCO December 21st Options Trading

Investors in Discovery Laboratories, Inc. saw new options become available this week, for the December 21st expiration.

First Week Of DSCO September 21st Options Trading

First Week Of DSCO September 21st Options Trading

Investors in Discovery Laboratories, Inc. saw new options begin trading this week, for the September 21st expiration.

5 Stocks Under $10 Set to Explode

5 Stocks Under $10 Set to Explode

These under-$10 stocks look poised to trade higher from current levels.

Shorting Alexza Pharma On FDA's Adasuve Approval

Shorting Alexza Pharma On FDA's Adasuve Approval

Alexza is setting up as a classic biotech run-down stock, says trader Mark Messier.

8 Stocks Under $10 Surging Higher

8 Stocks Under $10 Surging Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

7 Stocks Under $10 With Relative Strength

7 Stocks Under $10 With Relative Strength

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Poised for Upside

5 Stocks Under $10 Poised for Upside

These under-$10 stocks look ready to break out and trade higher from current levels.

For Biotech Takeovers, Timing is Key

For Biotech Takeovers, Timing is Key

Speculation swirls about a Vivus takeover, but history says an imminent deal isn't likely.

For Biotech, 'Fail' is Making a Big Comeback

For Biotech, 'Fail' is Making a Big Comeback

A series of disappointments and setbacks is cooling off the once red-hot biotech sector.

Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail

Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail

Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers.

Market Preview: The Bulls Finally Blink (Correct)

Market Preview: The Bulls Finally Blink (Correct)

Will February's believers become March's at-market sellers?

Pandora, Discovery Labs: After-Hours Trading (Update 1)

Pandora, Discovery Labs: After-Hours Trading (Update 1)

These stocks were attracting trading interest in Tuesday's after-hours session.